Press releases in 2003

 
23. 12. 2003
|

Slovene pharmaceutical company Lek d.d. has successfully defended its patent EP 1 095 037, which covers Lek’s synthesis of omeprazole before the Board of ...

 
3. 12. 2003
|

Today, the Slovene Chamber of Commerce, bestowed the award of Innovator of the Year 2002 to a group composed of Dr. Viktor Menart and ...

 
25. 11. 2003
|

Ljubljana, 25 November 2003 – After the settlement signed in July of 2003 between GlaxoSmithKline PLC (GSK) and Novartis, including Lek d.d. ...

 
15. 10. 2003
|

The pharmaceutical company Lek submitted adjusted prices for its leading products to the Agency for Medicinal Products of the Republic of Slovenia (the Agency). ...

 
25. 9. 2003
|

Ljubljana, 25 September 2003 – After years of fruitful cooperation, the co-founders and co-shareholders of Bayer Pharma d.o.o. decided on ownership change in Joint ...

 
3. 9. 2003
|

On Monday, 1 September 2003, the change of the company name and company headquarters of Lodz-based Argon SA was entered into the Court Register. ...

27. 8. 2003
|

On Monday, 25 August 2003, the President of the Polish Government, Mr Leszek Miller, visited Lek’s new plant, a Manufacturing and Logistics Centre in ...

 
21. 8. 2003
|

Novartis has taken a decision on Lek’s launching a generic omeprazole in the US market this week.

 
5. 8. 2003
|

We would like to inform you that the 19th General Meeting of Lek d.d. was held on Thursday, 31 July 2003, at the headquarters ...

 
18. 7. 2003
|

At the invitation of the company Lek d.d., Mr. Krzystof Makowski, Duke of the Polish Lodz region, came to visit Slovenia. During the visit, ...

 
1. 7. 2003
|

After the company Novartis had entered into the ownership structure of Lek d.d., the 2nd meeting of Lek Supervisory Board was held on Friday, ...

 
30. 6. 2003
|

On the basis of the Statute of the joint-stock company Lek, we hereby convene the 19th General Meeting of Lek d.d. to be held ...

 
16. 6. 2003
|

Following the cornerstone celebration at Lek’s Pharmaceutical Production and Logistics Centre in Stryków near Łódź in September last year, attended by Presidents Aleksander Kwaśniewski ...

 
14. 4. 2003
|

Based on one reported case from a pharmacy, received on Friday, April 11, Lek Pharmaceuticals, d.d. is informing the public that there was a ...

 
11. 4. 2003
|

A resolution on the ban on the distribution and use of the drug Dermo spray N, dermal spray produced by Lek d.d., was issued ...

 
28. 3. 2003
|

On Thursday, 27 March 2003, the newly appointed Supervisory Board of Lek Pharmaceuticals d.d. held its first meeting. The composition of the Supervisory Board ...

 
19. 3. 2003
|

The year 2002 was a major turning point for Lek – the takeover by the Swiss firm Servipharm AG, which is 100% owned by ...

 
4. 2. 2003
|

Lek Pharmaceuticals d.d., Verovškova 57, Ljubljana, hereby announces that

 
4. 2. 2003
|

A Slovenian pharmaceutical company, Lek Pharmaceuticals d.d., was granted by the US Food and Drug Administration (FDA) a final approval for the marketing ...

 
21. 1. 2003
|

Lek Pharmaceuticals d.d. hereby announces that they have issued, in accordance with Article 66 of the Act on Medicinal Products and Medical Devices, a ...

 
20. 1. 2003
|

Lek Pharmaceuticals d.d., Verovškova 57, Ljubljana, hereby announces that at the 18th General Meeting of the joint-stock company, held on 20 January 2003, Lek ...

 
6. 1. 2003
|

Ljubljana, January 6, 2003 – Lek d.d, a Slovene pharmaceutical company, has entered the world’s largest pharmaceuticals market with its leading product, co-amoxiclav. By ...